NCT04456504View on ClinicalTrials.gov

HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions
Healthcare Worker, Hepatitis B Vaccine, Nonresponder
Interventions
BIOLOGICAL

Recombinant hepatitis B vaccine with CpG adjuvant

Each participant will receive two doses of hepB-CpG separated by one month and blood draw to measure antibody to the hepatitis B surface antigen prior to dose 2 and one month after dose 2.

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT04456504 - HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders | Biotech Hunter | Biotech Hunter